Literature DB >> 1678479

Flare-up of rheumatoid arthritis during GM-CSF treatment after chemotherapy.

E G de Vries, P H Willemse, B Biesma, A C Stern, P C Limburg, E Vellenga.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1991        PMID： 1678479     DOI： 10.1016/0140-6736(91)90594-f

Source DB:  PubMed          Journal:  Lancet        ISSN： 0140-6736            Impact factor:   79.321


× No keyword cloud information.
  33 in total

Review 1.  Drug-induced rheumatic disorders: incidence, prevention and management.

Authors:  P Vergne; P Bertin; C Bonnet; C Scotto; R Trèves
Journal:  Drug Saf       Date:  2000-10       Impact factor: 5.606

Review 2.  [New biologics and orally available compounds. What is still in the pipeline?].

Authors:  M Grünke; H Bastian; H Schulze-Koops; G-R Burmester
Journal:  Z Rheumatol       Date:  2010-09       Impact factor: 1.372

Review 3.  Clinical toxicity of cytokines used as haemopoietic growth factors.

Authors:  T Vial; J Descotes
Journal:  Drug Saf       Date:  1995-12       Impact factor: 5.606

4.  Recombinant Granulocyte-Macrophage Colony-Stimulating Factor (rGM-CSF) : A Review of its Pharmacological Properties and Prospective Role in the Management of Myelosuppression.

Authors:  Susan M Grant; Rennie C Heel
Journal:  Drugs       Date:  1992-04       Impact factor: 9.546

Review 5.  Clinical role of GM-CSF in neutrophil recovery in relation to health care parameters.

Authors:  L S Hofstra; E G de Vries; C A Uyl-de Groot; E Vellenga
Journal:  Med Oncol       Date:  1996-09       Impact factor: 3.064

Review 6.  Selected cytokine pathways in rheumatoid arthritis.

Authors:  Mélissa Noack; Pierre Miossec
Journal:  Semin Immunopathol       Date:  2017-02-17       Impact factor: 9.623

Review 7.  Targeting Granulocyte-Monocyte Colony-Stimulating Factor Signaling in Rheumatoid Arthritis: Future Prospects.

Authors:  Chiara Crotti; Elena Agape; Andrea Becciolini; Martina Biggioggero; Ennio Giulio Favalli
Journal:  Drugs       Date:  2019-11       Impact factor: 9.546

8.  GM-CSF neutralisation suppresses inflammation and protects cartilage in acute streptococcal cell wall arthritis of mice.

Authors:  C Plater-Zyberk; L A B Joosten; M M A Helsen; J Hepp; P A Baeuerle; W B van den Berg
Journal:  Ann Rheum Dis       Date:  2006-10-04       Impact factor: 19.103

9.  Multi-response model for rheumatoid arthritis based on delay differential equations in collagen-induced arthritic mice treated with an anti-GM-CSF antibody.

Authors:  Gilbert Koch; Thomas Wagner; Christine Plater-Zyberk; Gezim Lahu; Johannes Schropp
Journal:  J Pharmacokinet Pharmacodyn       Date:  2011-12-23       Impact factor: 2.745

Review 10.  Use and toxicity of the colony-stimulating factors.

Authors:  J R Schriber; R S Negrin
Journal:  Drug Saf       Date:  1993-06       Impact factor: 5.606
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.